ELBW infants receive inadvertent sodium load above the recommended intake

Fabian Eibensteiner1, Gerda Laml-Wallner2, Margarita Thanhaeuser1

  • 1Department of Paediatrics, Division of Neonatology, Paediatric Intensice Care and Neuropaediatrics, Medical University of Vienna, Vienna, Austria.

Pediatric Research
|April 10, 2020
PubMed

Insights

Extremely low birth weight infants receive excessive sodium, increasing risks for bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, and mortality. Reducing inadvertent sodium intake is crucial for improving outcomes in these vulnerable newborns.

Area of Science:

  • Neonatalogy
  • Pediatric Nephrology
  • Clinical Nutrition

Background:

  • Extremely low birth weight (ELBW) infants often face significant fluid and electrolyte challenges.
  • Assessing total sodium load, including inadvertent sources, is critical for optimizing care.
  • Understanding sodium's impact on morbidity and mortality is essential for evidence-based neonatal practice.

Purpose of the Study:

  • To quantify total sodium intake in ELBW infants during the first two postnatal weeks.
  • To investigate the association between sodium load and serum sodium levels, morbidity, and mortality.
  • To develop and evaluate models for sodium replacement in ELBW infants.

Main Methods:

  • Retrospective analysis of data from ELBW infants with gestational age less than 28 weeks.
  • Inclusion of 90 infants with a median birth weight of 718g and gestational age of 24.9 weeks.
  • Calculation of sodium intake and correlation with clinical outcomes.

Main Results:

  • Median sodium intake (10.2 mmol/kg/day) significantly exceeded recommendations (2-5 mmol/kg/day).
  • Increased sodium intake correlated with higher risks of bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, and mortality.
  • No significant association found between sodium intake and hypernatremia risk.

Conclusions:

  • ELBW infants experience excessive sodium loads, primarily from inadvertent sources, linked to increased morbidity and mortality.
  • Alternative carrier solutions may reduce sodium intake, potentially improving infant outcomes.
  • Further research is needed to establish causality and refine sodium management strategies.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
178
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
630
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
176
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
357